Disclaimer:
This blog is for informational purposes only and should not be taken as medical advice. Content is sourced from third parties, and we do not guarantee accuracy or accept any liability for its use. Always consult a qualified healthcare professional for medical guidance.
Rectal cancer is a malignancy originating in the rectum, the final 12-15 cm of the large intestine, often as adenocarcinoma (95%) from glandular cells. It shares traits with colon cancer but has unique staging/treatment due to pelvic location. Stages 0-IV based on invasion/metastasis. In 2025, ~45,000 US cases, part of colorectal cancers, with declining rates from screening but rising in under-50s.
Symptoms include rectal bleeding (bright red blood), changes in bowel habits (diarrhea, constipation, narrow stools), abdominal/rectal pain, tenesmus (incomplete evacuation feeling), mucus discharge, fatigue/anemia, weight loss, and bowel obstruction in advanced cases. Symptoms mimic hemorrhoids/IBD, delaying diagnosis.
Genetic mutations (APC, KRAS) drive polyp-to-cancer progression. Risks include age (>50), family history, syndromes (Lynch, FAP), IBD, diet (high red meat/low fiber), obesity, smoking, alcohol, and sedentary lifestyle. In 2025, microbiome alterations contribute.
Screening (colonoscopy, FIT) detects early. Diagnosis involves digital rectal exam, colonoscopy/biopsy, CT/MRI for staging, and CEA monitoring. Molecular testing (MSI, KRAS) guides therapy. In 2025, AI colonoscopy enhances detection.
Localized uses neoadjuvant chemoradiation, then surgery (LAR, APR). Advanced adds chemotherapy (FOLFOX), targeted (bevacizumab), immunotherapy (for MSI-high). In 2025, organoid models personalize treatment.
In 2025, 5-year survival 67%, 90% localized. Advances like immunotherapy raise metastatic survival to 20%. By 2030, vaccines/AI could achieve 80% survival.
The information for rectal cancer is sourced from NCI’s “Rectal Cancer Treatment” for overview; Mayo Clinic’s “Rectal cancer – Symptoms and causes” for symptoms; PMC’s “Rectal Cancer: Current Trends and Future Perspectives” for updates; Healthline’s “Rectal Cancer: Symptoms, Causes, Diagnosis, and Treatment” for diagnosis; Cleveland Clinic’s “Rectal Cancer” for treatment.
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
1. Scan at your preferred center.
2. Written report from a specialist radiologist sent via email.
3. Access and download your scan images digitally.
4. Upon request, we can send the report and images to your doctor or hospital.
5. For self-referred patients, there is an additional charge of £30, which includes scan referral and a discussion with a private GP before and after the scan